Glass House Brands (GLAS) Total Current Liabilities (2020 - 2026)

Glass House Brands' (GLAS) quarterly Total Current Liabilities came in at $40.2 million in Q1 2026, up 5.89% year-on-year from $38.0 million in Q1 2025, and up 5.92% on a QoQ basis from $38.0 million in Q4 2025.

Glass House Brands (GLAS) Total Current Liabilities (2020 - 2026) Analysis & Trends

Glass House Brands (GLAS) has 7 years of Total Current Liabilities data on file, last reported at $40.2 million in Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 5.89% year-over-year to $40.2 million in Q1 2026; TTM through Mar 2026 was $40.2 million, a 5.89% increase from a year earlier, with the FY2025 full-year figure at $38.0 million, down 42.9% from the prior year.
  • Total Current Liabilities for Q1 2026 stood at $40.2 million, up from $38.0 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for GLAS reached as high as $97.0 million in Q1 2024 and fell as low as $33.2 million in Q3 2025.
  • Historically, Total Current Liabilities has averaged $64.6 million across 5 years, with a median of $62.1 million in 2023.
  • Across the five-year window, Total Current Liabilities soared 150.9% in 2022 and slumped 60.84% in 2025, its largest moves.
  • Year by year, Total Current Liabilities stood at $54.0 million in 2022, then soared by 61.77% to $87.4 million in 2023, then slipped by 23.9% to $66.5 million in 2024, then tumbled by 42.9% to $38.0 million in 2025, then increased by 5.92% to $40.2 million in 2026.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $40.2 million in Q1 2026, $38.0 million in Q4 2025, and $33.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - 6.56 Bn
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 13.53 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 2.05 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 18.06 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 599.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - 19.22 Mn
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 6.81 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 831.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 1.66 Bn
10 Glass House Brands 873.84 Mn 845.91 Mn 10.02 Mn 40.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 40.21 Mn
Dec 31, 2025 37.96 Mn
Sep 30, 2025 33.23 Mn
Jun 30, 2025 43.37 Mn
Mar 31, 2025 37.97 Mn
Dec 31, 2024 66.48 Mn
Sep 30, 2024 82.22 Mn
Jun 30, 2024 89.91 Mn
Mar 31, 2024 96.96 Mn
Dec 31, 2023 87.36 Mn
Sep 30, 2023 87.55 Mn
Jun 30, 2023 85.63 Mn
Mar 31, 2023 62.13 Mn
Dec 31, 2022 54.00 Mn
Sep 30, 2022 56.49 Mn
Jun 30, 2022 75.85 Mn
Mar 31, 2022 60.79 Mn
Dec 31, 2021 55.24 Mn
Sep 30, 2021 60.28 Mn
Jun 30, 2021 30.23 Mn